CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes Chief Operating Officer gave up 16,610 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 153,948 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 16,610 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes President & CEO gave up 162,815 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 16,958 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 20,093 shares (to pay taxes)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale President & CEO sold 45,000 shares at $29.90 ($1,345,500)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
Page 9 of 33 · 652 filings